BR0211830A - Dose única de azitromicina - Google Patents

Dose única de azitromicina

Info

Publication number
BR0211830A
BR0211830A BR0211830-0A BR0211830A BR0211830A BR 0211830 A BR0211830 A BR 0211830A BR 0211830 A BR0211830 A BR 0211830A BR 0211830 A BR0211830 A BR 0211830A
Authority
BR
Brazil
Prior art keywords
azithromycin
single dose
humans
administering
relates
Prior art date
Application number
BR0211830-0A
Other languages
English (en)
Inventor
Michael William Dunne
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0211830A publication Critical patent/BR0211830A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

"DOSE úNICA DE AZITROMICINA". A presente invenção refere-se a um método de tratamento de infecções respiratórias em seres humanos por administração de uma dose única de azitromicina.
BR0211830-0A 2001-08-21 2002-07-31 Dose única de azitromicina BR0211830A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21
PCT/IB2002/003076 WO2003018031A2 (en) 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections

Publications (1)

Publication Number Publication Date
BR0211830A true BR0211830A (pt) 2004-09-08

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211830-0A BR0211830A (pt) 2001-08-21 2002-07-31 Dose única de azitromicina

Country Status (25)

Country Link
US (3) US20030148964A1 (pt)
EP (1) EP1418924A2 (pt)
JP (1) JP2005501862A (pt)
KR (1) KR20040032942A (pt)
AP (1) AP1729A (pt)
BG (1) BG108537A (pt)
BR (1) BR0211830A (pt)
CA (1) CA2458135A1 (pt)
CZ (1) CZ2004232A3 (pt)
EA (1) EA200400214A1 (pt)
EC (1) ECSP044985A (pt)
GE (1) GEP20063812B (pt)
HR (1) HRP20040163A2 (pt)
HU (1) HUP0401332A2 (pt)
IL (1) IL159585A0 (pt)
IS (1) IS7092A (pt)
MA (1) MA27059A1 (pt)
MX (1) MXPA04001605A (pt)
OA (1) OA12845A (pt)
PL (1) PL367888A1 (pt)
SK (1) SK1012004A3 (pt)
TN (1) TNSN04035A1 (pt)
WO (1) WO2003018031A2 (pt)
YU (1) YU8804A (pt)
ZA (1) ZA200400804B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE421882T1 (de) * 2003-07-24 2009-02-15 Pliva Hrvatska D O O Schnellösliches azithromycin in einzeldosisform
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
CA2547774A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
LT1962805T (lt) 2005-12-08 2016-10-25 Insmed Incorporated Antiinfekcinės lipidų pagrindo kompozicijos, skirtos plaučių infekcijų gydymui
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
WO2009114810A2 (en) * 2008-03-14 2009-09-17 The Florida International Uinversity Board Of Trustees Use of ellagitannins as inhibitors of bacterial quorum sensing
EP2717909B1 (en) 2011-06-04 2017-12-06 Rochester General Hospital Research Institute Compositions and methods related to p6 of haemophilus influenzae
RU2675859C2 (ru) 2012-11-29 2018-12-25 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
EP3142643B1 (en) 2014-05-15 2019-07-10 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US20230149428A1 (en) * 2020-02-14 2023-05-18 Asklepios Biopharmaceutical, Inc. Method of treating gene therapy associated toxicity with antibiotics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (en) 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
YU45590A (sh) 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (pt) 1992-07-30 1996-03-01 Pfizer
DE69403963T2 (de) 1993-05-19 1997-11-20 Pfizer Zwischenprodukt für azithromycin
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
DE69524214T3 (de) 1994-05-06 2008-05-15 Pfizer Inc. Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
US7067493B2 (en) 2006-06-27
SK1012004A3 (sk) 2005-04-01
YU8804A (sh) 2006-08-17
WO2003018031A3 (en) 2003-10-02
ECSP044985A (es) 2004-04-28
CA2458135A1 (en) 2003-03-06
US20030148964A1 (en) 2003-08-07
MXPA04001605A (es) 2004-07-08
JP2005501862A (ja) 2005-01-20
HRP20040163A2 (en) 2005-02-28
IL159585A0 (en) 2004-06-01
AP1729A (en) 2007-03-26
US6987093B2 (en) 2006-01-17
HUP0401332A2 (hu) 2004-11-29
WO2003018031A2 (en) 2003-03-06
AP2004002968A0 (en) 2004-03-31
CZ2004232A3 (cs) 2005-10-12
MA27059A1 (fr) 2004-12-20
EA200400214A1 (ru) 2004-06-24
GEP20063812B (en) 2006-05-10
BG108537A (bg) 2005-02-28
TNSN04035A1 (fr) 2006-06-01
EP1418924A2 (en) 2004-05-19
IS7092A (is) 2003-12-23
PL367888A1 (en) 2005-03-07
KR20040032942A (ko) 2004-04-17
ZA200400804B (en) 2005-05-03
US20050250712A1 (en) 2005-11-10
US20040023898A1 (en) 2004-02-05
OA12845A (en) 2006-09-15

Similar Documents

Publication Publication Date Title
BR0211830A (pt) Dose única de azitromicina
BR0311126A (pt) Composições e método para tratar infecção em gado bovino e em suìnos
BR0209129A (pt) Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos
IL173002A (en) Use of calcitonin in the manufacture of oral medication for the prevention or treatment of osteoarthritis
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
AP2005003213A0 (en) 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
IL165893A0 (en) Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
BR0209658A (pt) Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR9911094A (pt) Composições e métodos para o tratamento detosse
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BRPI0503827A (pt) métodos para prevenir ou tratar infecções respiratórias em lactentes
SE0004101D0 (sv) New use
BR0317539A (pt) Métodos e composições para o tratamento de infecções por vìrus da herpes usando inibidores seletivos da ou ciclooxigenase-2 ou inibidores da ciclooxigenase-2 em combinação com agentes antivirais
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
DE602004019288D1 (de) Schnellösliches azithromycin in einzeldosisform
NO20054034L (no) Fremgangsmate for behandling av hypotyroidisme.
WO2003103699A8 (en) USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A A NUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE A 8.6, DA RPI 2108 DE 31/05/2011.